Clinical Trials in Seattle

Showing 6461-6480 of 9,312 trials

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

NCT01958970

This is a pilot study to assess the safety, pharmacokinetics and effectiveness of PINTA 745 or placebo in treating protein energy wasting (PEW) in patients receiving maintenance hemodialysis (MHD).

End Stage Renal DiseaseKidney DiseaseProtein Energy Wasting

Pinta Biotherapeutics51 participantsStarted Jan 2014

Lakewood, Colorado, United States • Orlando, Florida, United States • Minneapolis, Minnesota, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

NCT02558829

The Macimorelin Growth Hormone Stimulation Test (GHST) will be compared with the Insulin Tolerance Test (ITT) in an open-label, randomized, 2-way crossover Trial. The trial will include subjects suspected to have adult growth hormone deficiency (AGHD) and a group of healthy control subjects.

Growth Hormone Deficiency With Pituitary Anomalies

AEterna Zentaris157 participantsStarted Dec 2015

Torrance, California, United States • Austin, Texas, United States • Houston, Texas, United States +24 more locations

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

Find Trials by Condition in Seattle

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

People Presenting With Neurocysticercosis in North America

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.

An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

Monitoring Organ Donors to Increase Transplantation Results (MOnIToR)

Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes Mellitus

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

A Study in Patients With Type 2 Diabetes Mellitus

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer